Home » 3Z and Biotx.ai partnership to utilize AI modeling to advance ADHD drug development

To read the full story, subscribe or sign in.

Neurology/Psychiatric

3Z and Biotx.ai partnership to utilize AI modeling to advance ADHD drug development

Aug. 21, 2023

3Z ehf and Biotx.ai AG have established a strategic partnership to help advance the development of drugs for attention deficit hyperactivity disorder (ADHD).

BioWorld Science Artificial intelligence Drug design, drug delivery and technologies Collaboration Neurology/psychiatric